Assessing COVID-19 infection rates in patients with AML and MPN

COVID-19 and MPNПодробнее

Predicting outcomes for patients with leukemia and MDS after COVID-19 infectionПодробнее

Managing AML Patients During COVID-19Подробнее

The Effect of Covid-19 on AML TreatmentПодробнее

Responses to COVID-19 vaccination in patients with MDS and AMLПодробнее

COVID-19 occurrence and impact in hematological oncology patientsПодробнее

Identifying risk factors for severe COVID-19 in patients with AML, MDS and ALLПодробнее

Responses to COVID-19 vaccines in patients with AML and MDSПодробнее

Outcomes of MPN patients versus non-MPN patients hospitalized for COVID-19Подробнее

How does COVID-19 affect the outcomes of patients with AML?Подробнее

How COVID-19 Affects Patients With AMLПодробнее

What are the long-term effects of COVID-19 in patients with MPN?Подробнее

How does COVID-19 affect outcomes in AML?Подробнее

COVID-19 patterns in patients with MPNs in the first versus second wavesПодробнее

Impact of COVID-19 on AML treatment & managementПодробнее

Managing acute myeloid leukaemia during the COVID-19 pandemicПодробнее

COVID 19 Focus on High Risk MDS and Secondary AML PatientsПодробнее

COVID-19 and MPN updatesПодробнее

What AML Patients Should Know About the COVID-19 VaccinesПодробнее